References
- Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9
- Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456–88
- Cakmak H, Taylor HS. Human implantation failure: molecular mechanisms and clinical treatment. Human Reprod Update 2011;17:242–53
- Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). The Amsterdam ESHRE/ASRM – sponsored 3rd PCOS consensus workshop group. Fertil Steril 2012;97:28–38
- Giudice LC. Endometrium in PCOS: implantation and predisposition to endocrine cancers. Best Pract Res Clin Endocrinol Metab 2006;20:235–44
- Shang K, Jia X, Qiao J, et al. Endometrium abnormality in women with polycystic ovary syndrome. Reprod Sci 2012;19:674–83
- Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome: meta-analysis. Human Reprod 2012;27:1327–31
- Navaratnarajah R, Pillay OC, Hardiman P. Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med 2008;26:62–71
- Afratis N, Gialeli C, Nikitovic D, et al. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 2012;279:1177–97
- Gomes RCT, Maioral GCCC, Verna C, et al. Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle. Fertil Steril 2013;100:1419–27
- Nasciutti LE, Ferrari R, Berardo PT, et al. Distribution of chondroitin sulfate in human endometrium. Micron 2006;37:544–50
- Ueno M, Yamada S, Zako M, et al. Structural characterization of heparin sulphated and chondroitin sulphated of syndecan-1 purified from normal murine mammary glands epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence. J Biol Chem 2001;276:29134–40
- Volk R, Schwartz JJ, Li J, et al. The role of syndecan cytoplasmic domain in basic fibroblast growth factor-dependent signal transduction. J Biol Chem 1999;274:24417–24
- Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006;12:731–46
- Kresse H, Schonher E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001;189:266–74
- Sasisekharan R, Shriver Z, Venkataraman G, Narayanasami U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat Rev Cancer 2002;2:521–8
- Carson DD, Tang JP, Julian J. Heparan sulfate proteoglycan (perlecan) expression by mouse embryos during acquisition of attachment competence. Dev Biol 1993;155:97–106
- Atarashi K, Kawashima H, Hirata T, Miyasaka M. Chondroitin sulfate proteoglycan, common ligand of L-selectin and CD44. Tanpakushitsu Kakusan Koso 2002;47:2214–20
- Celie JW, Keuning ED, Beelen RH, et al. Identification of L-selectin binding heparan sulfates attached to collagen type XVIII. J Biol Chem 2005;280:26965–73
- Lopes IMRS, Baracat MCP, Simões MJ, et al. Endometrium in women with polycystic ovary syndrome during the window of implantation. Rev Assoc Med Bras 2011;57:688–95
- Park JC, Lim SY, Jang TK, et al. Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome. Clin Exp Reprod Med 2011;38:42–6
- Cattaruzza S, Perris R. Approaching the proteoglycome: molecular interactions of proteoglycans and their functional output. Macromol Biosci 2006;6:667–80
- Matsuo I, Kimura-Yoshida C. Extracellular modulation of fibroblast growth factor signaling through heparan sulfate proteoglycans in mammalian development. Curr Opin Genet Dev 2013;4:399–407